Clinical OMICs - Issue 3 - (Page 22)
(continued from previous page)
metabolites, organ-specific blood
proteins for the brain, heart, and liver
(measure general wellness to disease
transitions), white blood cell epigenetics, and salivary cortisol levels
(stress) four times a year.
We are working on new assays
to assess more effectively immune
responses and inflammation-signal
features of many different diseases. It
is important that rigorous standards
be created both for sample procurement and for assessing each of the
individual data types so that the data
can be integrated successfully and
mined for discovery.
We also believe that these data
must be shared freely among the
groups that are working together to
accelerate progress for the patients
who need the healthcare advances.
These data for each individual will be
aggregated, integrated, mined, and
models created to help prioritize the
actionable opportunities for each
individual. Developing the analytics
will be one of the largest challenges
of this study.
Actionable Possibilities
and Coaching
An actionable possibility is a feature
for an individual that, if corrected,
could improve wellness or avoid
disease. Let me give two examples.
A friend was told that he had early
onset osteoporosis in his mid-30s-a
disease that potentially could confine
him to a wheelchair for the rest of his
life. After genetic analysis, he discov-
22
Clinical OMICs May 15, 2014
The Institute for Systems Biology has presented an overview of the Hundred Person Wellness
Project.
ered that he had a defective calcium
transporter. He took 20 times the
normal amount of calcium for several
years and returned his bone structure
to normal. After about 12 years he
continues to remain normal on this
regimen. Thus this genetic defect is
actionable in that it can be corrected
by a vitamin.
A second example was a physicist
who began to lose interest in his work
and had difficulty concentrating and
finding the same joy in his life and
work as he had previously. After this
continued for a considerable time, he
began to question whether he should
completely change his life trajectory.
Upon undergoing blood screening, it
turned out that he was strikingly deficient in iron. Within days after replacement therapy he returned to normal
and resumed his former life with his
typical enthusiasm. In this case the
defect was an environmental deficiency that could readily be corrected.
We believe the genome has 300500 actionable genetic variants and
many of them lead to nutritional
deficiencies. Hence our feeling is that
every individual will have multiple
actionable possibilities that can be
corrected. An important point is that
new actionable possibilities will be
revealed as we integrate together different combinations of data.
We plan to have coaches that can
take these actionable possibilities
and explain them to the individuals, hopefully, in such a manner that
the individuals will be moved to act
upon their actionable possibilities. Of
course, physician oversight and treat-
www.clinicalomics.com
http://www.clinicalomics.com
Table of Contents for the Digital Edition of Clinical OMICs - Issue 3
Contents
Clinical OMICs - Issue 3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue15
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue14
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue13
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue1
https://www.nxtbookmedia.com